Cargando…

Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study

OBJECTIVE: This study was undertaken to evaluate the long‐term safety and effectiveness of fenfluramine in patients with Lennox–Gastaut syndrome (LGS). METHODS: Eligible patients with LGS who completed a 14‐week phase 3 randomized clinical trial enrolled in an open‐label extension (OLE; NCT03355209)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knupp, Kelly G., Scheffer, Ingrid E., Ceulemans, Berten, Sullivan, Joseph, Nickels, Katherine C., Lagae, Lieven, Guerrini, Renzo, Zuberi, Sameer M., Nabbout, Rima, Riney, Kate, Agarwal, Anupam, Lock, Michael, Dai, David, Farfel, Gail M., Galer, Bradley S., Gammaitoni, Arnold R., Polega, Shikha, Davis, Ronald, Gil‐Nagel, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099582/ https://www.ncbi.nlm.nih.gov/pubmed/36196777 http://dx.doi.org/10.1111/epi.17431

Ejemplares similares

Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial
por: Knupp, Kelly G., et al.
Publicado: (2022)

Fenfluramine HCl (Fintepla(®)) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study
por: Sullivan, Joseph, et al.
Publicado: (2020)

Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023)

Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023)

Low‐dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients
por: Schoonjans, A., et al.
Publicado: (2016)

Lennox-Gastaut syndrome: An overview
por: Ramanathan, Ramnath Santhosh, et al.
Publicado: (2010)

Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial
por: Nabbout, Rima, et al.
Publicado: (2020)

Fenfluramine: a plethora of mechanisms?
por: Sourbron, Jo, et al.
Publicado: (2023)

Lennox-Gastaut syndrome: Management update
por: Al-Banji, Muradi H., et al.
Publicado: (2015)

Lennox-Gastaut Syndrome: In a Nutshell
por: Jahngir, Muhammad Umair, et al.
Publicado: (2018)

Lennox-Gastaut Syndrome in Mitochondrial Disease
por: Lee, Soonie, et al.
Publicado: (2019)

Ophthalmologic Features of Lennox-Gastaut Syndrome
por: Kim, Bo Hee, et al.
Publicado: (2017)

Lennox-Gastaut and Schizophrenia: Comorbidity or complication?
por: Bencharfa, Z., et al.
Publicado: (2022)

The burden of illness in Lennox–Gastaut syndrome: a systematic literature review
por: Strzelczyk, Adam, et al.
Publicado: (2023)

Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine
por: Zhang, Yifan, et al.
Publicado: (2015)

The Curious Case of Lennox-Gastaut Syndrome: Treatment-Resistant Seizures in a Patient With Autism Spectrum Disease With Lennox-Gastaut Syndrome
por: Anvekar, Priyanka, et al.
Publicado: (2021)

Treatment of Lennox-Gastaut syndrome: overview and recent findings
por: van Rijckevorsel, Kenou
Publicado: (2008)

Surgical Treatment of Patients with Lennox-Gastaut Syndrome Phenotype
por: Liu, Shi-Yong, et al.
Publicado: (2012)

Anaesthetic management in a patient with Lennox-Gastaut syndrome
por: Dhansura, Tasneem, et al.
Publicado: (2014)

Lennox–Gastaut syndrome: impact on the caregivers and families of patients
por: Gibson, Patricia A
Publicado: (2014)

Cannabidiol for epilepsy (Lennox-Gastaut syndrome, Dravet syndrome)
Publicado: (2020)

Quantifying the burden of disease in patients with Lennox Gastaut syndrome
por: Spoor, Jochem K.H., et al.
Publicado: (2021)

A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects
por: Boyd, Brooks, et al.
Publicado: (2019)

Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study
por: Thiele, Elizabeth, et al.
Publicado: (2019)

Lennox gastaut syndrome, review of the literature and a case report
por: Abu Saleh, Tareq, et al.
Publicado: (2008)

Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
por: Stafstrom, Carl E
Publicado: (2009)

Conceptualizing Lennox–Gastaut Syndrome as a Secondary Network Epilepsy
por: Archer, John S., et al.
Publicado: (2014)

Lennox–Gastaut Syndrome: A Prospective Follow-up Study
por: Rathaur, Bhanu Pratap, et al.
Publicado: (2017)

Centromedian thalamic responsive neurostimulation for Lennox‐Gastaut epilepsy and autism
por: Kwon, Churl‐Su, et al.
Publicado: (2020)

Effect of Cannabinoids on Electroencephalography of a Child with Lennox–Gastaut Syndrome
por: Prakash, Vikram
Publicado: (2020)

Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea
por: Koo, Chung Mo, et al.
Publicado: (2020)

Unilateral Lennox–Gastaut syndrome associated with Klippel–Trénaunay syndrome
por: Tabarki, Brahim, et al.
Publicado: (2021)

Lennox–Gastaut Syndrome: Perspective of a Parent and a Physician
por: McKee, Heather R., et al.
Publicado: (2020)

ADHD in the context of Lennox Gastaut Syndrome: A rare presentation
por: B, Kavitha, et al.
Publicado: (2022)

Ketogenic Diets in the Management of Lennox-Gastaut Syndrome—Review of Literature
por: Skrobas, Urszula, et al.
Publicado: (2022)

Budget Impact Analysis of Antiepileptic Drugs for Lennox-Gastaut Syndrome
por: Skornicki, Michelle, et al.
Publicado: (2014)

Treatment of Focal-Onset Seizures in Children: Should This Be More Etiology-Driven?
por: Aeby, Alec, et al.
Publicado: (2022)

An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European Early Access Program
por: Guerrini, Renzo, et al.
Publicado: (2022)

Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy)
por: Kluger, Gerhard, et al.
Publicado: (2007)

Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome
por: Leahy, Jennifer T, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8acsdagq7pln7kbelcgmt1pqgg